Revenue

With Hepatitis C royalties declining, Enanta Pharmaceuticals faces investors this month to sell its vision: a future built on novel RSV and immunology drugs.

Regis Corp reports mixed FY26 results, but a deeper dive reveals a strategic turnaround. With operational gains and a key debt battle, is the salon giant set for growth?

Aedifica's absorption of Cofinimmo wasn't just a deal; it was a strategic masterstroke. An inside look at how this merger creates a healthcare real estate titan.

With a long-serving CFO out and ambitious Brazilian growth plans on the line, Serabi Gold bets on an interim leader to navigate a crucial transition.

Argo Corp. reports a stunning 680% revenue jump as its Smart Routing™ tech gains traction, securing new municipal contracts and a $10M investment.

Beyond the polish of IFA 2026, Levoit's new smart home tech reveals a deeper strategy by parent VeSync: to build an integrated wellness ecosystem, one quiet device at a time.

With AI reshaping cyber threats, Skyhigh Security appoints a new COO with a proven record of scaling tech giants. Can he turn market momentum into dominance?

As its CFO prepares for a key conference, Bio-Rad is navigating a major restructuring, activist pressure, and a divided market performance. What will he say?

A new 250MW data center and a bold partnership between HUMAIN and Together AI aim to leverage the Kingdom's vast power reserves to reshape the world's AI map.

With new products like Nexis and SST on the horizon and a renewed focus on storage, SolarEdge's upcoming Investor Day is a critical test of its growth strategy.

As operating costs soar and claim denials plague specialty practices, a mid-year revenue cycle check is emerging as a critical survival strategy.

Gaming giant GDEV is buying back $20M of its own shares amid falling revenue. Is this a bold signal of confidence or a defensive move in a tough market?

MarTech firm Zoomd posts a jarring year-over-year revenue drop but shows signs of a turnaround, leveraging AI for efficiency and a $22M war chest for growth.

In a stunning pivot, Healthy Choice Wellness Corp. is merging with Host Digital, landing a $1.25B data center lease likely backed by AI giants NVIDIA and CoreWeave.

Beyond the hype of new storefronts, High Tide's latest expansion reveals a disciplined, data-driven strategy that is reshaping Canada's cannabis market.

The Chinese lender's net loss explodes by 900%, yet it claims strategic success. A deep dive into the numbers reveals a story of survival amid a property crisis.

With its new COVID vaccine approved, Novavax is leveraging global partners like Sanofi to earn royalties, proving an asset-light model can rival industry giants.

After a strategic reset, Australian biopharma Immuron reports record sales and a stronger cash position, pivoting to partner its high-value drug candidates.

FinVolution's latest earnings show a stark contrast: a struggling domestic market and a booming overseas business. Is this the new fintech playbook?

A return to Q4 profitability, fueled by a direct-to-consumer surge and a key education deal, reveals Koss's new playbook for growth and diversification.